Changes in antischistosomal drug usage patterns in rural Qalyubia, Egypt.
To investigate the usage of antischistosomal drugs in the Nile Delta, an antischistosomal drug history was obtained by interview from a sample of inhabitants of the villages of Halaba (1,024, or every 4th household) and Kharkania (505, or every 20th household), south-central Nile Delta. Only 3% and 0.4% of participants, respectively, in the 2 villages reported receiving antischistosomal drugs during the previous 4 years. Most villagers received oral compounds (praziquantel and niridazole), and the treatment regimen was completed by 95%. This study reveals changes in antischistosomal drug usage since a study 8 years earlier in the village of Halaba, when most of the drugs were injectable compounds.
McNeeley
D F
DF
School of Public Health and Tropical Medicine, Tulane University, New Orleans, Louisiana.
Habib
M A
MA
Morgan
S H
SH
Azziz
F A
FA
Cline
B L
BL
D000284:Administration, Oral; D003365:Costs and Cost Analysis; D004534:Egypt; D005260:Female; D006801:Humans; D007407:Interviews as Topic; D008297:Male; D012424:Rural Population; D012553:Schistosomiasis haematobia / Q000188:drug therapy* / Q000517:prevention & control; D012556:Schistosomicides / Q000008:administration & dosage / Q000627:therapeutic use*; D011795:Surveys and Questionnaires
D012556:Schistosomicides